Oesophageal Carcinoma Terminated Phase 2 Trials for Docetaxel (DB01248)

Also known as: Carcinoma of Esophagus / Esophageal Carcinoma / Carcinoma, Esophageal / Esophagus Carcinoma / Carcinoma of oesophagus NOS / Carcinoma of oesophagus / Oesophageal carcinoma NOS / Esophageal carcinoma NOS

IndicationStatusPhase
DBCOND0032513 (Oesophageal Carcinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01608464Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus CancerTreatment